[Tumor-induced Hypophosphatemic Osteomalacia Caused by a Chest Wall Tumor]

Kyobu Geka. 2019 Aug;72(8):570-573.
[Article in Japanese]

Abstract

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic disease characterized by hypophosphatemia and skeletal undermineralization. Overproduction of fibroblast growth factor 23( FGF23) from the responsible tumor is reported to be a causative factor. Removing the tumor is the only effective treatment for TIO, but identifying the tumor is sometimes difficult. A 43-year-old man complained of heel pain 4 years earlier, and the pain gradually expanded to the whole body. As a blood test showed the elevation of the serum FGF23 level and hypophosphatemia, he was diagnosed with FGF23-related hypophosphatemia. Chest computed tomography (CT) showed a 10-mm nodule in the right chest wall. Venous sampling for FGF23 revealed considerable elevation of the FGF23 level in the right subclavian vein. Therefore, a chest wall tumor was suspected as the tumor responsible for TIO, and surgical resection was performed. After surgery, hypophosphatemia improved within several days, and the FGF23 level also normalized.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Fibroblast Growth Factor-23
  • Humans
  • Hypophosphatemia*
  • Male
  • Neoplasms, Connective Tissue*
  • Osteomalacia
  • Paraneoplastic Syndromes
  • Thoracic Wall*

Supplementary concepts

  • Oncogenic osteomalacia